AAF
NKTR icon

Andra AP-fonden’s Nektar Therapeutics NKTR Stock Holding History

Andra AP-fonden’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-1,433
Closed -$392K – 683
2019
Q3 		$392K Sell
1,433
-3,847
-73% -$1.41M 0.01% 650
2019
Q2 		$2.82M Sell
5,280
-1,500
-22% -$752K 0.08% 574
2019
Q1 		$3.42M Buy
+6,780
New +$4.02M 0.1% 525
2018
Q3 		$1.02M Buy
1,120
+67
+6% +$57.2K 0.03% 623
2018
Q2 		$772K Buy
+1,053
New +$1.21M 0.02% 635

Other funds holding NKTR

Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

Andra AP-fonden's NKTR Position: Q4 2019 in Review

Andra AP-fonden sold out of Nektar Therapeutics (NKTR) in Q4 2019, closing a stake of 1,433 shares — an estimated $392K sold.

Andra AP-fonden first reported a position in NKTR in Q2 2018 and held it in 5 quarters. The position peaked at $3.42M in Q1 2019. 281 funds tracked by Wall St. Rank hold NKTR as of Q4 2019.

  • Andra AP-fonden reported no remaining Nektar Therapeutics position as of Q4 2019 after selling out during the quarter.
  • Andra AP-fonden sold 1,433 Nektar Therapeutics shares in Q4 2019, an estimated $392K.
  • Andra AP-fonden first reported a position in Nektar Therapeutics in Q2 2018 and held it in 5 quarters.
  • Andra AP-fonden's Nektar Therapeutics position peaked at $3.42M in Q1 2019.
  • 281 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q4 2019.

Based on Andra AP-fonden's 13F filing for Q4 2019, filed 10 Feb 2020.